1. Home
  2. WELL vs ABT Comparison

WELL vs ABT Comparison

Compare WELL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Welltower Inc.

WELL

Welltower Inc.

HOLD

Current Price

$210.76

Market Cap

136.6B

Sector

Real Estate

ML Signal

HOLD

ABT

Abbott Laboratories

HOLD

Current Price

$101.91

Market Cap

183.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WELL
ABT
Founded
1970
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.6B
183.3B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
WELL
ABT
Price
$210.76
$101.91
Analyst Decision
Buy
Strong Buy
Analyst Count
13
18
Target Price
$224.38
$136.67
AVG Volume (30 Days)
2.4M
7.1M
Earning Date
04-28-2026
04-16-2026
Dividend Yield
1.40%
2.49%
EPS Growth
N/A
N/A
EPS
1.39
3.72
Revenue
$10,838,034,000.00
$44,328,000,000.00
Revenue This Year
$28.66
$10.10
Revenue Next Year
$6.03
$7.85
P/E Ratio
$151.66
$27.12
Revenue Growth
35.63
5.67
52 Week Low
$141.55
$99.05
52 Week High
$216.43
$137.49

Technical Indicators

Market Signals
Indicator
WELL
ABT
Relative Strength Index (RSI) 65.18 38.91
Support Level $182.12 $100.88
Resistance Level $215.49 $103.84
Average True Range (ATR) 3.77 2.04
MACD 1.32 0.12
Stochastic Oscillator 97.69 40.84

Price Performance

Historical Comparison
WELL
ABT

About WELL Welltower Inc.

Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: